Literature DB >> 16713163

Kinetic analysis of the humoral immune response against 3 Toxoplasma gondii-recombinant proteins in infants with suspected congenital toxoplasmosis.

Jaime Altcheh1, Natalia S Diaz, Carolina M Pepe, Valentina Martin, Monica Nigro, Hector Freilij, Sergio O Angel.   

Abstract

The reactivity values of Toxoplasma gondii ROP2, GRA4, and GRA7 recombinant antigens (rAgs) were analyzed by immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) in 23 congenitally infected (I) and 36 noninfected (NI) infants. The reactivity values observed from the serum samples of I versus NI infants for each recombinant protein were 91% versus 67% for rROP2 (P = .05), 86% versus 29% for rGRA4 (P < .001), and 56% versus 11% for rGRA7 (P = .003). The follow-up showed that serum samples from NI infants became negative for specific IgG at 5.8 months (95% confidence interval [CI], 4.9-6.7) using a commercial assay; meanwhile, by specific recombinant protein ELISA, the samples became negative at 3.7 months with rROP2 (95% CI, 2.8-4.6), at 1.3 months with rGRA4 (95% CI, 0.8-1.8), and at 0.9 months with rGRA7 (95% CI, 0.5-1.3). Kinetic analysis also showed that serum samples from group I presented different IgG-profiles among rAgs. The rROP2 IgG profile was similar to that of the commercial assay, whereas rGRA4 and rGRA7 profiles showed a gradual decrease along the period of the study. The potential of the utility of rAgs to develop a diagnostic system that discriminates congenitally I infants from NI is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713163     DOI: 10.1016/j.diagmicrobio.2006.03.012

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans.

Authors:  Pavlo Maksimov; Johannes Zerweck; Aline Maksimov; Andrea Hotop; Uwe Gross; Uwe Pleyer; Katrin Spekker; Walter Däubener; Sandra Werdermann; Olaf Niederstrasser; Eckhardt Petri; Marc Mertens; Rainer G Ulrich; Franz J Conraths; Gereon Schares
Journal:  Clin Vaccine Immunol       Date:  2012-04-11

2.  Characterization and evaluation of a recombinant multiepitope peptide antigen MAG in the serological diagnosis of Toxoplasma gondii infection in pigs.

Authors:  Yongle Song; Yongjuan Zhao; Ke Pan; Bang Shen; Rui Fang; Min Hu; Junlong Zhao; Yanqin Zhou
Journal:  Parasit Vectors       Date:  2021-08-17       Impact factor: 3.876

3.  Selection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotyping.

Authors:  Susana Sousa; Daniel Ajzenberg; Maggy Marle; Dominique Aubert; Isabelle Villena; José Correia da Costa; Marie-Laure Dardé
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

4.  GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis.

Authors:  Lucyna Holec-Gasior; Józef Kur; Elzbieta Hiszczyńska-Sawicka
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

5.  Sero-diagnostic evaluation of Toxoplasma gondii recombinant Rhoptry antigen 8 expressed in E. coli.

Authors:  Parthasarathy Sonaimuthu; Mun Yik Fong; Ramaswamy Kalyanasundaram; Rohela Mahmud; Yee Ling Lau
Journal:  Parasit Vectors       Date:  2014-07-01       Impact factor: 3.876

6.  Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli.

Authors:  Jalal Babaie; Mandana Miri; Ghazaleh Sadeghiani; Mehrak Zare; Ghader Khalili; Majid Golkar
Journal:  Avicenna J Med Biotechnol       Date:  2011-04

7.  Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4.

Authors:  Yanhua Wang; Guangxiang Wang; Jiangtao Ou; Hong Yin; Delin Zhang
Journal:  Parasit Vectors       Date:  2014-10-10       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.